nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—PPARG—Sulfasalazine—ankylosing spondylitis	0.683	0.733	CbGbCtD
Glipizide—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0532	0.057	CbGbCtD
Glipizide—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0403	0.0432	CbGbCtD
Glipizide—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0346	0.0371	CbGbCtD
Glipizide—CYP3A4—Betamethasone—ankylosing spondylitis	0.0346	0.0371	CbGbCtD
Glipizide—CYP3A4—Prednisolone—ankylosing spondylitis	0.0341	0.0366	CbGbCtD
Glipizide—CYP3A4—Prednisone—ankylosing spondylitis	0.0322	0.0346	CbGbCtD
Glipizide—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0201	0.0216	CbGbCtD
Glipizide—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.000344	0.00509	CcSEcCtD
Glipizide—Vision blurred—Prednisolone—ankylosing spondylitis	0.000344	0.00509	CcSEcCtD
Glipizide—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.000343	0.00508	CcSEcCtD
Glipizide—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.000338	0.00501	CcSEcCtD
Glipizide—Visual impairment—Dexamethasone—ankylosing spondylitis	0.000337	0.00498	CcSEcCtD
Glipizide—Visual impairment—Betamethasone—ankylosing spondylitis	0.000337	0.00498	CcSEcCtD
Glipizide—Erythema—Triamcinolone—ankylosing spondylitis	0.000335	0.00496	CcSEcCtD
Glipizide—Erythema—Methylprednisolone—ankylosing spondylitis	0.000334	0.00495	CcSEcCtD
Glipizide—Malaise—Prednisolone—ankylosing spondylitis	0.000329	0.00487	CcSEcCtD
Glipizide—Vertigo—Prednisolone—ankylosing spondylitis	0.000328	0.00485	CcSEcCtD
Glipizide—Syncope—Prednisolone—ankylosing spondylitis	0.000327	0.00484	CcSEcCtD
Glipizide—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000327	0.00483	CcSEcCtD
Glipizide—Eye disorder—Betamethasone—ankylosing spondylitis	0.000327	0.00483	CcSEcCtD
Glipizide—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00032	0.00474	CcSEcCtD
Glipizide—Hypertension—Prednisolone—ankylosing spondylitis	0.000315	0.00466	CcSEcCtD
Glipizide—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.000312	0.00462	CcSEcCtD
Glipizide—Arrhythmia—Betamethasone—ankylosing spondylitis	0.000312	0.00462	CcSEcCtD
Glipizide—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000311	0.0046	CcSEcCtD
Glipizide—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00031	0.00459	CcSEcCtD
Glipizide—Discomfort—Prednisolone—ankylosing spondylitis	0.000307	0.00454	CcSEcCtD
Glipizide—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.000305	0.00451	CcSEcCtD
Glipizide—Erythema—Dexamethasone—ankylosing spondylitis	0.000304	0.0045	CcSEcCtD
Glipizide—Erythema—Betamethasone—ankylosing spondylitis	0.000304	0.0045	CcSEcCtD
Glipizide—Malaise—Triamcinolone—ankylosing spondylitis	0.000302	0.00447	CcSEcCtD
Glipizide—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000302	0.00447	CcSEcCtD
Glipizide—Malaise—Methylprednisolone—ankylosing spondylitis	0.000302	0.00446	CcSEcCtD
Glipizide—Vertigo—Triamcinolone—ankylosing spondylitis	0.000301	0.00446	CcSEcCtD
Glipizide—Syncope—Triamcinolone—ankylosing spondylitis	0.000301	0.00445	CcSEcCtD
Glipizide—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000301	0.00445	CcSEcCtD
Glipizide—Syncope—Methylprednisolone—ankylosing spondylitis	0.0003	0.00444	CcSEcCtD
Glipizide—Oedema—Prednisolone—ankylosing spondylitis	0.000298	0.0044	CcSEcCtD
Glipizide—Dysuria—Methotrexate—ankylosing spondylitis	0.000297	0.0044	CcSEcCtD
Glipizide—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000295	0.00436	CcSEcCtD
Glipizide—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000294	0.00435	CcSEcCtD
Glipizide—Shock—Prednisolone—ankylosing spondylitis	0.000293	0.00433	CcSEcCtD
Glipizide—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.00029	0.00429	CcSEcCtD
Glipizide—Hypertension—Triamcinolone—ankylosing spondylitis	0.000289	0.00428	CcSEcCtD
Glipizide—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000289	0.00427	CcSEcCtD
Glipizide—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000288	0.00426	CcSEcCtD
Glipizide—Myalgia—Triamcinolone—ankylosing spondylitis	0.000285	0.00422	CcSEcCtD
Glipizide—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000285	0.00422	CcSEcCtD
Glipizide—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000285	0.00422	CcSEcCtD
Glipizide—Eye disorder—Prednisone—ankylosing spondylitis	0.000284	0.00421	CcSEcCtD
Glipizide—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000284	0.0042	CcSEcCtD
Glipizide—Drowsiness—Methotrexate—ankylosing spondylitis	0.000283	0.00419	CcSEcCtD
Glipizide—Flushing—Prednisone—ankylosing spondylitis	0.000282	0.00418	CcSEcCtD
Glipizide—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000282	0.00418	CcSEcCtD
Glipizide—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000282	0.00418	CcSEcCtD
Glipizide—Discomfort—Triamcinolone—ankylosing spondylitis	0.000282	0.00417	CcSEcCtD
Glipizide—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000281	0.00416	CcSEcCtD
Glipizide—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000275	0.00408	CcSEcCtD
Glipizide—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000275	0.00407	CcSEcCtD
Glipizide—Malaise—Betamethasone—ankylosing spondylitis	0.000274	0.00406	CcSEcCtD
Glipizide—Malaise—Dexamethasone—ankylosing spondylitis	0.000274	0.00406	CcSEcCtD
Glipizide—Oedema—Triamcinolone—ankylosing spondylitis	0.000274	0.00405	CcSEcCtD
Glipizide—Vertigo—Betamethasone—ankylosing spondylitis	0.000273	0.00405	CcSEcCtD
Glipizide—Vertigo—Dexamethasone—ankylosing spondylitis	0.000273	0.00405	CcSEcCtD
Glipizide—Syncope—Betamethasone—ankylosing spondylitis	0.000273	0.00404	CcSEcCtD
Glipizide—Syncope—Dexamethasone—ankylosing spondylitis	0.000273	0.00404	CcSEcCtD
Glipizide—Arrhythmia—Prednisone—ankylosing spondylitis	0.000272	0.00402	CcSEcCtD
Glipizide—Sweating—Methotrexate—ankylosing spondylitis	0.000272	0.00402	CcSEcCtD
Glipizide—Shock—Triamcinolone—ankylosing spondylitis	0.000269	0.00398	CcSEcCtD
Glipizide—Insomnia—Prednisolone—ankylosing spondylitis	0.000269	0.00398	CcSEcCtD
Glipizide—Shock—Methylprednisolone—ankylosing spondylitis	0.000269	0.00398	CcSEcCtD
Glipizide—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000268	0.00397	CcSEcCtD
Glipizide—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000267	0.00396	CcSEcCtD
Glipizide—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000267	0.00396	CcSEcCtD
Glipizide—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000267	0.00395	CcSEcCtD
Glipizide—Erythema—Prednisone—ankylosing spondylitis	0.000265	0.00392	CcSEcCtD
Glipizide—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000264	0.00391	CcSEcCtD
Glipizide—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000264	0.00391	CcSEcCtD
Glipizide—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000264	0.00391	CcSEcCtD
Glipizide—Hypertension—Betamethasone—ankylosing spondylitis	0.000263	0.00389	CcSEcCtD
Glipizide—Hypertension—Dexamethasone—ankylosing spondylitis	0.000263	0.00389	CcSEcCtD
Glipizide—Myalgia—Dexamethasone—ankylosing spondylitis	0.000259	0.00383	CcSEcCtD
Glipizide—Myalgia—Betamethasone—ankylosing spondylitis	0.000259	0.00383	CcSEcCtD
Glipizide—Anxiety—Betamethasone—ankylosing spondylitis	0.000258	0.00382	CcSEcCtD
Glipizide—Anxiety—Dexamethasone—ankylosing spondylitis	0.000258	0.00382	CcSEcCtD
Glipizide—Discomfort—Betamethasone—ankylosing spondylitis	0.000256	0.00379	CcSEcCtD
Glipizide—Discomfort—Dexamethasone—ankylosing spondylitis	0.000256	0.00379	CcSEcCtD
Glipizide—Pain—Prednisolone—ankylosing spondylitis	0.000254	0.00377	CcSEcCtD
Glipizide—Hepatitis—Methotrexate—ankylosing spondylitis	0.000254	0.00376	CcSEcCtD
Glipizide—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000252	0.00374	CcSEcCtD
Glipizide—Vision blurred—Prednisone—ankylosing spondylitis	0.00025	0.0037	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000249	0.00369	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000249	0.00368	CcSEcCtD
Glipizide—Oedema—Betamethasone—ankylosing spondylitis	0.000248	0.00367	CcSEcCtD
Glipizide—Oedema—Dexamethasone—ankylosing spondylitis	0.000248	0.00367	CcSEcCtD
Glipizide—Insomnia—Triamcinolone—ankylosing spondylitis	0.000247	0.00366	CcSEcCtD
Glipizide—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000247	0.00365	CcSEcCtD
Glipizide—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000246	0.00364	CcSEcCtD
Glipizide—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000246	0.00364	CcSEcCtD
Glipizide—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000245	0.00363	CcSEcCtD
Glipizide—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000245	0.00363	CcSEcCtD
Glipizide—Visual impairment—Methotrexate—ankylosing spondylitis	0.000245	0.00363	CcSEcCtD
Glipizide—Shock—Dexamethasone—ankylosing spondylitis	0.000244	0.00362	CcSEcCtD
Glipizide—Shock—Betamethasone—ankylosing spondylitis	0.000244	0.00362	CcSEcCtD
Glipizide—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000244	0.00361	CcSEcCtD
Glipizide—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000243	0.0036	CcSEcCtD
Glipizide—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000243	0.0036	CcSEcCtD
Glipizide—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000241	0.00356	CcSEcCtD
Glipizide—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00024	0.00356	CcSEcCtD
Glipizide—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00024	0.00355	CcSEcCtD
Glipizide—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00024	0.00355	CcSEcCtD
Glipizide—Malaise—Prednisone—ankylosing spondylitis	0.000239	0.00354	CcSEcCtD
Glipizide—Vertigo—Prednisone—ankylosing spondylitis	0.000238	0.00352	CcSEcCtD
Glipizide—Eye disorder—Methotrexate—ankylosing spondylitis	0.000238	0.00352	CcSEcCtD
Glipizide—Syncope—Prednisone—ankylosing spondylitis	0.000238	0.00352	CcSEcCtD
Glipizide—Anorexia—Dexamethasone—ankylosing spondylitis	0.000237	0.0035	CcSEcCtD
Glipizide—Anorexia—Betamethasone—ankylosing spondylitis	0.000237	0.0035	CcSEcCtD
Glipizide—Urticaria—Prednisolone—ankylosing spondylitis	0.000236	0.0035	CcSEcCtD
Glipizide—Pain—Triamcinolone—ankylosing spondylitis	0.000234	0.00346	CcSEcCtD
Glipizide—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000233	0.00345	CcSEcCtD
Glipizide—Hypertension—Prednisone—ankylosing spondylitis	0.000229	0.00339	CcSEcCtD
Glipizide—Chills—Methotrexate—ankylosing spondylitis	0.000228	0.00338	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000226	0.00335	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000226	0.00335	CcSEcCtD
Glipizide—Arthralgia—Prednisone—ankylosing spondylitis	0.000226	0.00334	CcSEcCtD
Glipizide—Myalgia—Prednisone—ankylosing spondylitis	0.000226	0.00334	CcSEcCtD
Glipizide—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000225	0.00334	CcSEcCtD
Glipizide—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000225	0.00333	CcSEcCtD
Glipizide—Anxiety—Prednisone—ankylosing spondylitis	0.000225	0.00333	CcSEcCtD
Glipizide—Insomnia—Betamethasone—ankylosing spondylitis	0.000225	0.00332	CcSEcCtD
Glipizide—Insomnia—Dexamethasone—ankylosing spondylitis	0.000225	0.00332	CcSEcCtD
Glipizide—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000223	0.0033	CcSEcCtD
Glipizide—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000223	0.0033	CcSEcCtD
Glipizide—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000223	0.0033	CcSEcCtD
Glipizide—Discomfort—Prednisone—ankylosing spondylitis	0.000223	0.0033	CcSEcCtD
Glipizide—Erythema—Methotrexate—ankylosing spondylitis	0.000221	0.00328	CcSEcCtD
Glipizide—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000219	0.00324	CcSEcCtD
Glipizide—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000219	0.00323	CcSEcCtD
Glipizide—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000219	0.00323	CcSEcCtD
Glipizide—Urticaria—Triamcinolone—ankylosing spondylitis	0.000217	0.00322	CcSEcCtD
Glipizide—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000217	0.00321	CcSEcCtD
Glipizide—Oedema—Prednisone—ankylosing spondylitis	0.000216	0.0032	CcSEcCtD
Glipizide—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000216	0.00319	CcSEcCtD
Glipizide—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000216	0.00319	CcSEcCtD
Glipizide—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000216	0.00319	CcSEcCtD
Glipizide—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000214	0.00317	CcSEcCtD
Glipizide—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000214	0.00317	CcSEcCtD
Glipizide—Shock—Prednisone—ankylosing spondylitis	0.000213	0.00315	CcSEcCtD
Glipizide—Pain—Betamethasone—ankylosing spondylitis	0.000212	0.00314	CcSEcCtD
Glipizide—Pain—Dexamethasone—ankylosing spondylitis	0.000212	0.00314	CcSEcCtD
Glipizide—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000209	0.00309	CcSEcCtD
Glipizide—Vision blurred—Methotrexate—ankylosing spondylitis	0.000209	0.00309	CcSEcCtD
Glipizide—Anorexia—Prednisone—ankylosing spondylitis	0.000206	0.00305	CcSEcCtD
Glipizide—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000205	0.00304	CcSEcCtD
Glipizide—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000205	0.00303	CcSEcCtD
Glipizide—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000205	0.00303	CcSEcCtD
Glipizide—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000203	0.003	CcSEcCtD
Glipizide—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000203	0.003	CcSEcCtD
Glipizide—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000202	0.00298	CcSEcCtD
Glipizide—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000201	0.00298	CcSEcCtD
Glipizide—Malaise—Methotrexate—ankylosing spondylitis	0.0002	0.00296	CcSEcCtD
Glipizide—Vertigo—Methotrexate—ankylosing spondylitis	0.000199	0.00294	CcSEcCtD
Glipizide—Leukopenia—Methotrexate—ankylosing spondylitis	0.000198	0.00293	CcSEcCtD
Glipizide—Urticaria—Betamethasone—ankylosing spondylitis	0.000197	0.00292	CcSEcCtD
Glipizide—Urticaria—Dexamethasone—ankylosing spondylitis	0.000197	0.00292	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000197	0.00292	CcSEcCtD
Glipizide—Dizziness—Prednisolone—ankylosing spondylitis	0.000197	0.00291	CcSEcCtD
Glipizide—Asthenia—Triamcinolone—ankylosing spondylitis	0.000196	0.00291	CcSEcCtD
Glipizide—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000196	0.0029	CcSEcCtD
Glipizide—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000196	0.0029	CcSEcCtD
Glipizide—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000196	0.0029	CcSEcCtD
Glipizide—Insomnia—Prednisone—ankylosing spondylitis	0.000196	0.00289	CcSEcCtD
Glipizide—Paraesthesia—Prednisone—ankylosing spondylitis	0.000194	0.00287	CcSEcCtD
Glipizide—Pruritus—Triamcinolone—ankylosing spondylitis	0.000194	0.00287	CcSEcCtD
Glipizide—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000193	0.00286	CcSEcCtD
Glipizide—Dyspepsia—Prednisone—ankylosing spondylitis	0.00019	0.00282	CcSEcCtD
Glipizide—Arthralgia—Methotrexate—ankylosing spondylitis	0.000188	0.00279	CcSEcCtD
Glipizide—Myalgia—Methotrexate—ankylosing spondylitis	0.000188	0.00279	CcSEcCtD
Glipizide—Decreased appetite—Prednisone—ankylosing spondylitis	0.000188	0.00278	CcSEcCtD
Glipizide—Rash—Prednisolone—ankylosing spondylitis	0.000188	0.00278	CcSEcCtD
Glipizide—Dermatitis—Prednisolone—ankylosing spondylitis	0.000187	0.00277	CcSEcCtD
Glipizide—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000187	0.00276	CcSEcCtD
Glipizide—Headache—Prednisolone—ankylosing spondylitis	0.000186	0.00276	CcSEcCtD
Glipizide—Discomfort—Methotrexate—ankylosing spondylitis	0.000186	0.00276	CcSEcCtD
Glipizide—Constipation—Prednisone—ankylosing spondylitis	0.000185	0.00274	CcSEcCtD
Glipizide—Confusional state—Methotrexate—ankylosing spondylitis	0.000182	0.0027	CcSEcCtD
Glipizide—Dizziness—Triamcinolone—ankylosing spondylitis	0.000181	0.00268	CcSEcCtD
Glipizide—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000181	0.00267	CcSEcCtD
Glipizide—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000178	0.00264	CcSEcCtD
Glipizide—Asthenia—Betamethasone—ankylosing spondylitis	0.000178	0.00264	CcSEcCtD
Glipizide—Asthenia—Dexamethasone—ankylosing spondylitis	0.000178	0.00264	CcSEcCtD
Glipizide—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000177	0.00262	CcSEcCtD
Glipizide—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000177	0.00262	CcSEcCtD
Glipizide—Nausea—Prednisolone—ankylosing spondylitis	0.000177	0.00262	CcSEcCtD
Glipizide—Pruritus—Dexamethasone—ankylosing spondylitis	0.000176	0.0026	CcSEcCtD
Glipizide—Pruritus—Betamethasone—ankylosing spondylitis	0.000176	0.0026	CcSEcCtD
Glipizide—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000175	0.00259	CcSEcCtD
Glipizide—Vomiting—Triamcinolone—ankylosing spondylitis	0.000174	0.00257	CcSEcCtD
Glipizide—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000174	0.00257	CcSEcCtD
Glipizide—Rash—Triamcinolone—ankylosing spondylitis	0.000173	0.00255	CcSEcCtD
Glipizide—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000172	0.00255	CcSEcCtD
Glipizide—Anorexia—Methotrexate—ankylosing spondylitis	0.000172	0.00255	CcSEcCtD
Glipizide—Rash—Methylprednisolone—ankylosing spondylitis	0.000172	0.00255	CcSEcCtD
Glipizide—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000172	0.00255	CcSEcCtD
Glipizide—Urticaria—Prednisone—ankylosing spondylitis	0.000172	0.00254	CcSEcCtD
Glipizide—Headache—Triamcinolone—ankylosing spondylitis	0.000171	0.00254	CcSEcCtD
Glipizide—Headache—Methylprednisolone—ankylosing spondylitis	0.000171	0.00253	CcSEcCtD
Glipizide—Abdominal pain—Prednisone—ankylosing spondylitis	0.000171	0.00253	CcSEcCtD
Glipizide—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00017	0.00251	CcSEcCtD
Glipizide—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00017	0.00251	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000165	0.00244	CcSEcCtD
Glipizide—Dizziness—Dexamethasone—ankylosing spondylitis	0.000164	0.00243	CcSEcCtD
Glipizide—Dizziness—Betamethasone—ankylosing spondylitis	0.000164	0.00243	CcSEcCtD
Glipizide—Insomnia—Methotrexate—ankylosing spondylitis	0.000163	0.00242	CcSEcCtD
Glipizide—Nausea—Triamcinolone—ankylosing spondylitis	0.000163	0.00241	CcSEcCtD
Glipizide—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000162	0.0024	CcSEcCtD
Glipizide—Nausea—Methylprednisolone—ankylosing spondylitis	0.000162	0.0024	CcSEcCtD
Glipizide—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000161	0.00238	CcSEcCtD
Glipizide—Somnolence—Methotrexate—ankylosing spondylitis	0.000161	0.00238	CcSEcCtD
Glipizide—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000159	0.00236	CcSEcCtD
Glipizide—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000159	0.00235	CcSEcCtD
Glipizide—Vomiting—Betamethasone—ankylosing spondylitis	0.000158	0.00234	CcSEcCtD
Glipizide—Vomiting—Dexamethasone—ankylosing spondylitis	0.000158	0.00234	CcSEcCtD
Glipizide—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000157	0.00232	CcSEcCtD
Glipizide—Rash—Dexamethasone—ankylosing spondylitis	0.000157	0.00232	CcSEcCtD
Glipizide—Rash—Betamethasone—ankylosing spondylitis	0.000157	0.00232	CcSEcCtD
Glipizide—Dermatitis—Betamethasone—ankylosing spondylitis	0.000156	0.00231	CcSEcCtD
Glipizide—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000156	0.00231	CcSEcCtD
Glipizide—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000156	0.00231	CcSEcCtD
Glipizide—Headache—Dexamethasone—ankylosing spondylitis	0.000156	0.0023	CcSEcCtD
Glipizide—Headache—Betamethasone—ankylosing spondylitis	0.000156	0.0023	CcSEcCtD
Glipizide—Asthenia—Prednisone—ankylosing spondylitis	0.000155	0.0023	CcSEcCtD
Glipizide—Pain—Methotrexate—ankylosing spondylitis	0.000155	0.00229	CcSEcCtD
Glipizide—Pruritus—Prednisone—ankylosing spondylitis	0.000153	0.00226	CcSEcCtD
Glipizide—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000149	0.0022	CcSEcCtD
Glipizide—Diarrhoea—Prednisone—ankylosing spondylitis	0.000148	0.00219	CcSEcCtD
Glipizide—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000148	0.00219	CcSEcCtD
Glipizide—Nausea—Betamethasone—ankylosing spondylitis	0.000147	0.00218	CcSEcCtD
Glipizide—Nausea—Dexamethasone—ankylosing spondylitis	0.000147	0.00218	CcSEcCtD
Glipizide—Urticaria—Methotrexate—ankylosing spondylitis	0.000144	0.00212	CcSEcCtD
Glipizide—Dizziness—Prednisone—ankylosing spondylitis	0.000143	0.00212	CcSEcCtD
Glipizide—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000143	0.00211	CcSEcCtD
Glipizide—Vomiting—Prednisone—ankylosing spondylitis	0.000137	0.00203	CcSEcCtD
Glipizide—Rash—Prednisone—ankylosing spondylitis	0.000136	0.00202	CcSEcCtD
Glipizide—Dermatitis—Prednisone—ankylosing spondylitis	0.000136	0.00202	CcSEcCtD
Glipizide—Headache—Prednisone—ankylosing spondylitis	0.000135	0.002	CcSEcCtD
Glipizide—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000133	0.00197	CcSEcCtD
Glipizide—Asthenia—Methotrexate—ankylosing spondylitis	0.00013	0.00192	CcSEcCtD
Glipizide—Nausea—Prednisone—ankylosing spondylitis	0.000128	0.0019	CcSEcCtD
Glipizide—Pruritus—Methotrexate—ankylosing spondylitis	0.000128	0.00189	CcSEcCtD
Glipizide—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000124	0.00183	CcSEcCtD
Glipizide—Dizziness—Methotrexate—ankylosing spondylitis	0.000119	0.00177	CcSEcCtD
Glipizide—Vomiting—Methotrexate—ankylosing spondylitis	0.000115	0.0017	CcSEcCtD
Glipizide—Rash—Methotrexate—ankylosing spondylitis	0.000114	0.00169	CcSEcCtD
Glipizide—Dermatitis—Methotrexate—ankylosing spondylitis	0.000114	0.00168	CcSEcCtD
Glipizide—Headache—Methotrexate—ankylosing spondylitis	0.000113	0.00168	CcSEcCtD
Glipizide—Nausea—Methotrexate—ankylosing spondylitis	0.000107	0.00159	CcSEcCtD
